Genomic landscape of late-stage gastric cancer

被引：3

作者：

Janjigian, Y. Y. ^{[1
]}

Cecchini, M. ^{[2
]}

Shitara, K. ^{[3
]}

Enzinger, P. C. ^{[4
,5
]}

Wainberg, Z. A. ^{[6
]}

Catenacci, D. V. ^{[7
]}

Chau, I. ^{[8
]}

Satoh, T. ^{[9
]}

Lee, J. ^{[10
]}

Loboda, A. ^{[11
]}

Kobie, J. ^{[11
]}

Li, Y. ^{[11
]}

Shih, C-S. ^{[11
]}

Cristescu, R. ^{[11
]}

Cao, Z. A. ^{[11
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA

[2] Yale Sch Med, Med Oncol, New Haven, CT USA

[3] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

[4] Dana Farber Canc Inst, Gastrointestinal Canc Ctr, Boston, MA 02115 USA

[5] Harvard Med Sch, Boston, MA 02115 USA

[6] Univ Calif Los Angeles, David Geffen Sch Med, Med Hematol & Oncol, Los Angeles, CA 90095 USA

[7] Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA

[8] Royal Marsden NHS Fdn Trust, Royal Marsden Sutton, Dept Med, Sutton, Surrey, England

[9] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Osaka, Japan

[10] Sungkyunkwan Univ, Div Hematol Oncol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea

[11] Merck & Co Inc, Med Oncol, Kenilworth, NJ USA

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.08.1525

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1416P

引用

页码：S1062 / S1063

页数：2

共 50 条

[41] Cancer drug falters during late-stage trials
Butler, R
CHEMISTRY & INDUSTRY, 2004, (09) : 9 - 9
[42] Upregulation of Bone Morphogenetic Protein 1 Is Associated with Poor Prognosis of Late-Stage Gastric Cancer Patients
Deng, Yi-Fang
Hsieh, Yung-Yu
Tung, Shui-Yi
Pan, Hung-Yu
Yen, Chih-Wei
Xu, Huang-Wei
Lin, Ying-Jhen
Hsu, Wan-Ting
Chan, Michael W. Y.
Wu, Cheng-Shyong
Li, Chin
CANCER SCIENCE, 2018, 109 : 1079 - 1079
[43] CLINICAL AND EXPERIMENTAL STUDIES OF JPYS IN REDUCING SIDE-EFFECTS OF CHEMOTHERAPY IN LATE-STAGE GASTRIC CANCER
余桂清
任德麟
孙桂芝
张代钊
Journal of Traditional Chinese Medicine, 1993, (01) : 31 - 37
[44] Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients
Yung-Yu Hsieh
Shui-Yi Tung
Hung-Yu Pan
Chih-Wei Yen
Huang-Wei Xu
Yi-Fang Deng
Ying-Jhen Lin
Wan-Ting Hsu
Cheng-Shyong Wu
Chin Li
BMC Cancer, 18
[45] Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients
Hsieh, Yung-Yu
Tung, Shui-Yi
Pan, Hung-Yu
Yen, Chih-Wei
Xu, Huang-Wei
Deng, Yi-Fang
Lin, Ying-Jhen
Hsu, Wan-Ting
Wu, Cheng-Shyong
Li, Chin
BMC CANCER, 2018, 18
[46] Breakdown 2.0? Systemic Blockages in Late-Stage Statism and Late-Stage Liberal Capitalism
Stalder, Felix
AMERICAN BEHAVIORAL SCIENTIST, 2023, 67 (07) : 872 - 884
[47] Designing cancer screening trials for reduction in late-stage cancer incidence
Zhu, Kehao
Zhao, Ying-Qi
Zheng, Yingye
BIOMETRICS, 2024, 80 (03)
[48] PLASMAPHERESIS FOR LATE-STAGE TRYPANOSOMIASIS
SPINAZZOLA, F
DEFELICI, A
PAGLIA, MG
TOCCI, G
GALGANI, S
DAMATO, C
GIANNUZZI, R
STRUGLIA, C
VISCO, G
COTRONEO, E
LANCET, 1989, 1 (8648): : 1200 - 1200
[49] Late-stage sinking of plutons
Glazner, AF
Miller, DM
GEOLOGY, 1997, 25 (12) : 1099 - 1102
[50] Electrochemical Late-Stage Functionalization
Wang, Yulei
Dana, Suman
Long, Hao
Xu, Yang
Li, Yanjun
Kaplaneris, Nikolaos
Ackermann, Lutz
CHEMICAL REVIEWS, 2023, 123 (19) : 11269 - 11335

← 1 2 3 4 5 →